Publications - Success stories - Rhumatologie - Facultatif
INTRODUCTION
find the whole article here ==>doi: 10.1183/13993003.03130-2021
Authors
Humbert M, Bourdin A, Taillé C, Kamar D, Thonnelier C, Lajoinie A, Rigault A, Deschildre A, Molimard M.
The French Healthcare Database System (SNDS) was used to identify asthma patients aged ≥6 years who initiated omalizumab for at least 16 weeks from 2009 to 2019. We examined omalizumab treatment patterns using dispensation records.
.